136 related articles for article (PubMed ID: 18607883)
1. Cellular senescence in oral cancer and precancer and treatment implications: a review.
Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Llamas-Martínez S; Lo Muzio L; Bascones-Martínez A
Acta Oncol; 2008; 47(8):1464-74. PubMed ID: 18607883
[TBL] [Abstract][Full Text] [Related]
2. Tumour biology: senescence in premalignant tumours.
Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
[TBL] [Abstract][Full Text] [Related]
3. Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs.
Kim KW; Chung HN; Ha KY; Lee JS; Kim YY
Spine J; 2009 Aug; 9(8):658-66. PubMed ID: 19540815
[TBL] [Abstract][Full Text] [Related]
4. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans.
Bascones-Martínez A; López-Durán M; Cano-Sánchez J; Sánchez-Verde L; Díez-Rodríguez A; Aguirre-Echebarría P; Alvarez-Fernández E; González-Moles MA; Bascones-Ilundain J; Muzio LL; Campo-Trapero J
Oncol Lett; 2012 Jun; 3(6):1319-1325. PubMed ID: 22783442
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
6. Update on molecular pathology in oral cancer and precancer.
Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Sánchez-Gutierrez JJ; González-Moles MA; Bascones-Martínez A
Anticancer Res; 2008; 28(2B):1197-205. PubMed ID: 18505056
[TBL] [Abstract][Full Text] [Related]
7. Senescence and pre-malignancy: how do tumors progress?
Saab R
Semin Cancer Biol; 2011 Dec; 21(6):385-91. PubMed ID: 21982725
[TBL] [Abstract][Full Text] [Related]
8. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
9. Senescence as a modulator of oral squamous cell carcinoma development.
Parkinson EK
Oral Oncol; 2010 Dec; 46(12):840-53. PubMed ID: 21050803
[TBL] [Abstract][Full Text] [Related]
10. Senescence and immortality in hepatocellular carcinoma.
Ozturk M; Arslan-Ergul A; Bagislar S; Senturk S; Yuzugullu H
Cancer Lett; 2009 Dec; 286(1):103-13. PubMed ID: 19070423
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks for senescence in carcinogenesis: novel signaling players.
Caino MC; Meshki J; Kazanietz MG
Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
[TBL] [Abstract][Full Text] [Related]
12. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer.
Acha A; Ruesga MT; Rodríguez MJ; Martínez de Pancorbo MA; Aguirre JM
Med Oral Patol Oral Cir Bucal; 2005; 10(2):95-102. PubMed ID: 15735540
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
15. Cellular senescence in vivo: a barrier to tumorigenesis.
Prieur A; Peeper DS
Curr Opin Cell Biol; 2008 Apr; 20(2):150-5. PubMed ID: 18353625
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy in the management of oral cancer: review of the literature.
Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
18. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.
Leikam C; Hufnagel A; Schartl M; Meierjohann S
Oncogene; 2008 Nov; 27(56):7070-82. PubMed ID: 18806824
[TBL] [Abstract][Full Text] [Related]
19. Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence.
Helmbold H; Kömm N; Deppert W; Bohn W
Oncogene; 2009 Oct; 28(39):3456-67. PubMed ID: 19648966
[TBL] [Abstract][Full Text] [Related]
20. Senescence: the good the bad and the dysfunctional.
Pazolli E; Stewart SA
Curr Opin Genet Dev; 2008 Feb; 18(1):42-7. PubMed ID: 18262406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
